EDGEWOOD, Md. (Business Wire) -- After five years, approximately 14 million dollars, and with the use of over a dozen healthcare facilities, the Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT) sponsored by the National Institutes of Health and led by various clinical investigators, has released an abstract of findings in this landmark study.
The double blind, placebo controlled study was designed to evaluate the efficacy of glucosamine, chondroitin sulfate, glucosamine/chondroitin sulfate combination (all ingredients required to meet pharmaceutical standards), and celecoxib in joint pain. The chondroitin sulfate selected for use in the GAIT study is ONLY found in Cosamin(R)DS, a combination of glucosamine HCl and chondroitin sulfate, marketed by Nutramax Laboratories, Inc. The chondroitin sulfate is supplied by Bioiberica SA under an exclusive agreement with Nutramax Laboratories, Inc.(1)
The GAIT study was designed to rigorously assess the efficacy and safety of glucosamine and chondroitin sulfate alone and in combination. The glucosamine and chondroitin sulfate used were required to meet pharmaceutical standards as GAIT was conducted under an Investigational New Drug application (see abstract).
The study arose from need: "1 out of 3 Americans experience joint pain from Osteoarthritis" (American College of Rheumatology). The resulting health care cost impacted by this number is $82 billion. The study conclusion reads: "Combination glucosamine + chondroitin sulfate is effective in treating moderate to severe knee pain due to Osteoarthritis." (79.2%)
CosaminDS was the first glucosamine HCl (hydrochloride) chondroitin sulfate combination product on the market. It is manufactured following standards practiced by the pharmaceutical industry. "We're very pleased, but not surprised by the outcome," stated Dr. Robert Henderson, President of Nutramax Laboratories, Inc. and the pharmacist who literally invented the nutraceutical joint health industry by developing CosaminDS.
Dr. Henderson continues, "CosaminDS is the only brand proven effective in controlled, published, U.S. studies to reduce joint pain. Now, the prestigious world renowned health research organization has released an abstract of their study. And, they selected the exact chondroitin sulfate found only in CosaminDS (US), based on its quality and purity for use in this study."
David Moore, Vice President of the Consumer Products division adds, "CosaminDS has been used in other clinical trials published in medical journals. That's why it's the number one orthopedic surgeons and rheumatologists recommended brand(2). This landmark study supports the findings of previous studies."
CosaminDS launched in the spring of 1992. After its success, many competitive products have joined the market but no other glucosamine/chondroitin sulfate combination product is equivalent to CosaminDS in formula, safety or efficacy.
About Nutramax Laboratories, Inc.:
Nutramax Laboratories, Inc. researches, develops, and markets products to support the active lifestyles of people and animals. The corporate entity has two business divisions: Consumer Products and Veterinary Science. Nutramax Laboratories Consumer Products Division markets Cosamin(R)DS joint health supplement that contains the exclusive chondroitin sulfate selected for inclusion by the National Institutes of Health (NIH) GAIT study and is the number one recommended brand by orthopedic surgeons and rheumatologists(2). Nutramax Laboratories Veterinary Science Division markets Cosequin(R) the #1 veterinarian-recommended joint health supplement brand.(3)
To read the full text of the abstract, visit: http://www.rheumatology.org/annual/index.asp
(1) http://nccam.nih.gov/news/19972000/121100/qa.htm
(2) SLACK Incorporated Market Research Survey, June, 2005, July 2003, November 2001 and April 2000. Surveys conducted of Orthopedic Surgeons & Rheumatologists relating to glucosamine/chondroitin sulfate brands
(3) Surveys conducted in October 2001 and March 2004 of small animal veterinarians who recommended oral joint health supplements. Surveys conducted in the Fall of 2002 and March 2004 of equine veterinarians who recommended oral joint health supplements.
VNR: Satellite Feed Times and Coordinates:
------------------------------------------
Friday, September 30, 2005 --- 11:00-11:15 AM ET
Friday, September 30, 2005 --- 2:00-2:15 PM ET
(Coordinates the same for all feeds)
Galaxy 3 (c-band) Transponder 3
Downlink 3760 (H) Audio 6.2 & 6.8
For Questions or Technical Assistance, Please Contact Jeremy Franklin
at 817-794-0555
Nutramax Laboratories, Inc.
Nancy Belle, 410-776-4035
nbelle@nutramaxlabs.com
© Business Wire
Only GlobeinvestorGOLD combines the strength of powerful investing tools with the insight of The Globe and Mail.
Discover a wealth of investment information and and exclusive features.
